Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Public Health | Research article

Hepatitis B virus infection and its associated factors among medical waste collectors at public health facilities in eastern Ethiopia: a facility-based cross-sectional study

Authors: Degu Abate Mengiste, Abebe Tolera Dirbsa, Behailu Hawulte Ayele, Tewodros Tesfa Hailegiyorgis

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

The risk of hepatitis B virus infection among medical waste handlers who undergo collection, transportation, and disposal of medical wastes in the health institutions is higher due to frequent exposure to contaminated blood and other body fluids. There is limited evidence on the seroprevalence of hepatitis B among medical waste handlers in eastern Ethiopia. The study was aimed at studying the seroprevalence of Hepatitis B Virus and associated risk factors among medical waste collectors at health facilities of eastern Ethiopia.

Methods

A facility-based cross-sectional study was conducted among randomly selected medical waste collectors from public health facilities in eastern Ethiopia from March to June 2018. A pre-tested and well-structured questionnaire was used to collect data on socio-demographic characteristics and hepatitis B infection risk factors. A2.5ml venous blood was also collected, centrifuged and the serum was analyzed for hepatitis B surface antigen using the instant hepatitis B surface antigen kit. Descriptive summary measures were done. Chi-square and Fisher exact tests were used to assess the risk of association. Multivariate logistic regression was conducted with 95% CI and all value at P-value < 0.05 was declared statistically significant.

Results

From a total of 260 (97.38%) medical waste collectors participated, HBV was detected in 53 (20.4%) of the participants [95%CI; 15.8, 25.6]. No significant differences were observed in the detection rates of HBV with respect to socio-demographic characteristics. In both bivariate and multivariable logistic regression analysis, being unvaccinated (AOR = 6.35; 95%CI = [2.53–15.96], P = 0.001), history of blood transfusion (receiving) (AOR; 3.54; 95%CI; [1.02–12.24], P = 0.046), history of tattooing (AOR = 2.86; 95%CI = [1.12–7.27], p = 0.03), and history of multiple sexual partner (AOR = 10.28; 95%CI = [4.16–25.38], P = 0.001) remained statistically significantly associated with HBsAg positivity.

Conclusion

This cross-sectional study identified that HBV infection is high among medical waste collectors in eastern Ethiopia. Immunization and on job health promotion and disease prevention measures should be considered in order to control the risk of HBV infection among medical waste collectors in eastern Ethiopia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Amsalu A, Worku M, Tadesse E, Shimelis T. The exposure rate to hepatitis B and C viruses among medical waste handlers in three government hospitals, southern Ethiopia. Epidemiol Health. 2016;38:e2016001-e. Amsalu A, Worku M, Tadesse E, Shimelis T. The exposure rate to hepatitis B and C viruses among medical waste handlers in three government hospitals, southern Ethiopia. Epidemiol Health. 2016;38:e2016001-e.
2.
go back to reference Shiferaw Y, Abebe T, Mihret A. Sharps injuries and exposure to blood and bloodstained body fluids involving medical waste handlers. Waste Manag Res. 2012;30(12):1299–305.CrossRef Shiferaw Y, Abebe T, Mihret A. Sharps injuries and exposure to blood and bloodstained body fluids involving medical waste handlers. Waste Manag Res. 2012;30(12):1299–305.CrossRef
3.
go back to reference Jang YC, Lee C, Yoon OS, Kim H. Medical waste management in Korea. J Environ Manag. 2006;80(2):107–15.CrossRef Jang YC, Lee C, Yoon OS, Kim H. Medical waste management in Korea. J Environ Manag. 2006;80(2):107–15.CrossRef
4.
go back to reference Rachiotis G, Papagiannis D, Markas D, Thanasias E, Dounias G, Hadjichristodoulou C. Hepatitis B virus infection and waste collection: Prevalence, risk factors, and infection pathway. Am J Ind Med. 2012;55(7):650–5. https://doi.org/10.1002/ajim.22057. Rachiotis G, Papagiannis D, Markas D, Thanasias E, Dounias G, Hadjichristodoulou C. Hepatitis B virus infection and waste collection: Prevalence, risk factors, and infection pathway. Am J Ind Med. 2012;55(7):650–5. https://​doi.​org/​10.​1002/​ajim.​22057.
5.
go back to reference Duffell EF, van de Laar MJW, Amato-Gauci AJ. Enhanced surveillance of hepatitis B in the EU, 2006–2012. J Viral Hepat. 2015;22(7):581–9.CrossRef Duffell EF, van de Laar MJW, Amato-Gauci AJ. Enhanced surveillance of hepatitis B in the EU, 2006–2012. J Viral Hepat. 2015;22(7):581–9.CrossRef
6.
go back to reference Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–9.CrossRef Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–9.CrossRef
7.
go back to reference Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941–53.CrossRef Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941–53.CrossRef
8.
11.
go back to reference Shiferaw Y, Abebe T, Mihret A. Hepatitis B virus infection among medical waste handlers in Addis Ababa, Ethiopia. BMC Research Notes. 2011;4(1):479.CrossRef Shiferaw Y, Abebe T, Mihret A. Hepatitis B virus infection among medical waste handlers in Addis Ababa, Ethiopia. BMC Research Notes. 2011;4(1):479.CrossRef
12.
go back to reference Anagaw B, Shiferaw Y, Anagaw B, Belyhun Y, Erku W, Biadgelegn F, et al. Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town health institutions, Northwest Ethiopia. BMC Research Notes. 2012;5(1):55.CrossRef Anagaw B, Shiferaw Y, Anagaw B, Belyhun Y, Erku W, Biadgelegn F, et al. Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town health institutions, Northwest Ethiopia. BMC Research Notes. 2012;5(1):55.CrossRef
13.
go back to reference Belyhun Y, Maier M, Mulu A, Diro E, Liebert UG. Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016;16(1):761.CrossRef Belyhun Y, Maier M, Mulu A, Diro E, Liebert UG. Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016;16(1):761.CrossRef
15.
go back to reference Harhay MO, Halpern SD, Harhay JS, Olliaro PL. Health care waste management: a neglected and growing public health problem worldwide. Tropical Med Int Health. 2009;14(11):1414–7.CrossRef Harhay MO, Halpern SD, Harhay JS, Olliaro PL. Health care waste management: a neglected and growing public health problem worldwide. Tropical Med Int Health. 2009;14(11):1414–7.CrossRef
16.
go back to reference Debere MK, Gelaye KA, Alamdo AG, Trifa ZM. Assessment of the health care waste generation rates and its management system in hospitals of Addis Ababa, Ethiopia, 2011. BMC Public Health. 2013;13(1):28.CrossRef Debere MK, Gelaye KA, Alamdo AG, Trifa ZM. Assessment of the health care waste generation rates and its management system in hospitals of Addis Ababa, Ethiopia, 2011. BMC Public Health. 2013;13(1):28.CrossRef
17.
go back to reference Anozie OB, Lawani LO, Eze JN, Mamah EJ, Onoh RC, Ogah EO, et al. Knowledge, attitude and practice of healthcare managers to medical waste management and occupational safety practices: findings from Southeast Nigeria. J Clin Diagn Res. 2017;11(3):IC01–IC4.PubMedPubMedCentral Anozie OB, Lawani LO, Eze JN, Mamah EJ, Onoh RC, Ogah EO, et al. Knowledge, attitude and practice of healthcare managers to medical waste management and occupational safety practices: findings from Southeast Nigeria. J Clin Diagn Res. 2017;11(3):IC01–IC4.PubMedPubMedCentral
18.
go back to reference Al-Marrani WHM, Al-Shamahy HAJUJPR. Prevalence of HBV and HCV; and their associated risk factors among public health center cleaners at selected Public Health Centers in Sana'a city-Yemen. Journal of Pharmaceutical Research. 2018;3(5):63–67. Al-Marrani WHM, Al-Shamahy HAJUJPR. Prevalence of HBV and HCV; and their associated risk factors among public health center cleaners at selected Public Health Centers in Sana'a city-Yemen. Journal of Pharmaceutical Research. 2018;3(5):63–67.
19.
go back to reference Otovwe A, Adidatimi PO. Knowledge, Attitude and Practice of standard precaution among Health Care Workers in Federal Medical Centre Yenagoa, Nigeria, IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)e-ISSN:2278–3008, p-ISSN:2319–7676. Volume 12, Issue 4 Ver. III, PP 79–86, www.iosrjournals.org 2017. Otovwe A, Adidatimi PO. Knowledge, Attitude and Practice of standard precaution among Health Care Workers in Federal Medical Centre Yenagoa, Nigeria, IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)e-ISSN:2278–3008, p-ISSN:2319–7676. Volume 12, Issue 4 Ver. III, PP 79–86, www.​iosrjournals.​org 2017.
20.
go back to reference de Titto E, Savino AA, Townend WK. Healthcare waste management: the current issues in developing countries. London: SAGE Publications Sage UK; 2012. de Titto E, Savino AA, Townend WK. Healthcare waste management: the current issues in developing countries. London: SAGE Publications Sage UK; 2012.
21.
go back to reference Franka E, El-Zoka AH, Hussein AH, Elbakosh MM, Arafa AK, Ghenghesh KS. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya. J Hospital Infection. 2009;72(3):258–61.CrossRef Franka E, El-Zoka AH, Hussein AH, Elbakosh MM, Arafa AK, Ghenghesh KS. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya. J Hospital Infection. 2009;72(3):258–61.CrossRef
22.
go back to reference Mol MPG, Gonçalves JP, Silva EA, Scarponi CF, Greco DB, Cairncross S, et al. Seroprevalence of hepatitis B and C among domestic and healthcare waste handlers in Belo Horizonte, Brazil. Waste Manag Res. 2016;34(9):875–83.CrossRef Mol MPG, Gonçalves JP, Silva EA, Scarponi CF, Greco DB, Cairncross S, et al. Seroprevalence of hepatitis B and C among domestic and healthcare waste handlers in Belo Horizonte, Brazil. Waste Manag Res. 2016;34(9):875–83.CrossRef
23.
go back to reference Okpokam DC, Kooffreh-Ada M, Okhormhe ZA, Ernest NA, Nna VU. Sensitivity comparison between rapid one-step test strip and ELISA methods in detection of HBsAg among selected chronic liver disease patients in University of Calabar Teaching hospital, Calabar, Nigeria. Asian J Med Sci. 2015;6(5):56–60.CrossRef Okpokam DC, Kooffreh-Ada M, Okhormhe ZA, Ernest NA, Nna VU. Sensitivity comparison between rapid one-step test strip and ELISA methods in detection of HBsAg among selected chronic liver disease patients in University of Calabar Teaching hospital, Calabar, Nigeria. Asian J Med Sci. 2015;6(5):56–60.CrossRef
24.
go back to reference Yizengaw E, Getahun T, Geta M, Mulu W, Ashagrie M, Hailu D, et al. Sero-prevalence of hepatitis B virus infection and associated factors among health care workers and medical waste handlers in primary hospitals of north-West Ethiopia. Bmc Research Notes. 2018;11(1):437. https://doi.org/10.1186/s13104-018-3538-8. Yizengaw E, Getahun T, Geta M, Mulu W, Ashagrie M, Hailu D, et al. Sero-prevalence of hepatitis B virus infection and associated factors among health care workers and medical waste handlers in primary hospitals of north-West Ethiopia. Bmc Research Notes. 2018;11(1):437. https://​doi.​org/​10.​1186/​s13104-018-3538-8.
25.
go back to reference Chiarakul S, Eunumjitkul K, Vuttiopas S, Vorapimol A, Kaewkungwal J, Poovorawan YJJ-MAOT. Seroprevalence and risk factors of hepatitis B virus infection among health care workers at the Institute of Neurology 2007;90(8):1536. Chiarakul S, Eunumjitkul K, Vuttiopas S, Vorapimol A, Kaewkungwal J, Poovorawan YJJ-MAOT. Seroprevalence and risk factors of hepatitis B virus infection among health care workers at the Institute of Neurology 2007;90(8):1536.
26.
go back to reference Shao ER, Mboya IB, Gunda DW, Ruhangisa FG, Temu EM, Nkwama ML, et al. Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania. BMC Infect Dis. 2018;18(1):474.CrossRef Shao ER, Mboya IB, Gunda DW, Ruhangisa FG, Temu EM, Nkwama ML, et al. Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania. BMC Infect Dis. 2018;18(1):474.CrossRef
27.
go back to reference Akibu M, Nurgi S, Tadese M, Tsega WD. Attitude and vaccination status of healthcare workers against hepatitis B infection in a teaching hospital, Ethiopia. Scientifica. 2018;2018. Akibu M, Nurgi S, Tadese M, Tsega WD. Attitude and vaccination status of healthcare workers against hepatitis B infection in a teaching hospital, Ethiopia. Scientifica. 2018;2018.
28.
go back to reference López-Menchero C, Alvarez M, Fernández P, Guzmán M, Ortiz-de-Salazar MI, Arbona C. Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the region of Valencia, Spain, during a 15-year period (2003-2017). Blood Transfus. 2019;17(6):418–27.PubMedPubMedCentral López-Menchero C, Alvarez M, Fernández P, Guzmán M, Ortiz-de-Salazar MI, Arbona C. Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the region of Valencia, Spain, during a 15-year period (2003-2017). Blood Transfus. 2019;17(6):418–27.PubMedPubMedCentral
29.
go back to reference Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion. 2001;41(7):878–84.CrossRef Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion. 2001;41(7):878–84.CrossRef
30.
go back to reference Muktar HM, Suleiman AM, Jones M. Safety of blood transfusion: prevalence of hepatitis B surface antigen in blood donors in Zaria, northern Nigeria. Niger J Surg Res. 2005;7(3):290–2. Muktar HM, Suleiman AM, Jones M. Safety of blood transfusion: prevalence of hepatitis B surface antigen in blood donors in Zaria, northern Nigeria. Niger J Surg Res. 2005;7(3):290–2.
31.
go back to reference Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J. 2016;13(1):76.CrossRef Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J. 2016;13(1):76.CrossRef
32.
go back to reference Loua A, Sow EM, Magassouba FB, Camara M, Baldé MA. Evaluation of residual infectious risk among blood donors in National Center of blood transfusion in Conakry. Transfusion Clinique et Biologique. 2004;11(2):98–100.CrossRef Loua A, Sow EM, Magassouba FB, Camara M, Baldé MA. Evaluation of residual infectious risk among blood donors in National Center of blood transfusion in Conakry. Transfusion Clinique et Biologique. 2004;11(2):98–100.CrossRef
33.
go back to reference Biadgo B, Shiferaw E, Woldu B, Alene KA, Melku M. Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, Northwest Ethiopia: a three year retrospective study. PLoS One. 2017;12(7):e0180416.CrossRef Biadgo B, Shiferaw E, Woldu B, Alene KA, Melku M. Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, Northwest Ethiopia: a three year retrospective study. PLoS One. 2017;12(7):e0180416.CrossRef
34.
go back to reference Shiferaw F, Letebo M, Bane A. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BMC Public Health. 2016;16(1):769.CrossRef Shiferaw F, Letebo M, Bane A. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BMC Public Health. 2016;16(1):769.CrossRef
35.
go back to reference Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT, et al. Investing in non-communicable disease prevention and management to advance the sustainable development goals. Lancet. 2018;391(10134):2029–35.CrossRef Nugent R, Bertram MY, Jan S, Niessen LW, Sassi F, Jamison DT, et al. Investing in non-communicable disease prevention and management to advance the sustainable development goals. Lancet. 2018;391(10134):2029–35.CrossRef
36.
go back to reference Shiferaw F, Letebo M, Misganaw A, Feleke Y, Gelibo T, Getachew T, et al. Non-communicable Diseases in Ethiopia: Disease burden, gaps in health care delivery and strategic directions. Ethiopian J Health Development. 2018;32(3). Shiferaw F, Letebo M, Misganaw A, Feleke Y, Gelibo T, Getachew T, et al. Non-communicable Diseases in Ethiopia: Disease burden, gaps in health care delivery and strategic directions. Ethiopian J Health Development. 2018;32(3).
37.
go back to reference Hauri AM, Armstrong GL, Hutin YJJIjoS, AIDS. The global burden of disease attributable to contaminated injections given in health care settings 2004;15(1):7–16. Hauri AM, Armstrong GL, Hutin YJJIjoS, AIDS. The global burden of disease attributable to contaminated injections given in health care settings 2004;15(1):7–16.
38.
go back to reference Makuza JD, Rwema JOT, Ntihabose CK, Dushimiyimana D, Umutesi J, Nisingizwe MP, et al. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infect Dis. 2019;19(1):381.CrossRef Makuza JD, Rwema JOT, Ntihabose CK, Dushimiyimana D, Umutesi J, Nisingizwe MP, et al. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infect Dis. 2019;19(1):381.CrossRef
39.
go back to reference MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5(5):a021410-a. MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5(5):a021410-a.
40.
go back to reference Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. North Am J Med Sci. 2011;4(1). Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. North Am J Med Sci. 2011;4(1).
41.
go back to reference Alter MJ, Margolis HS. The emergence of hepatitis B as a sexually transmitted disease. Med Clin N Am. 1990;74(6):1529–41.CrossRef Alter MJ, Margolis HS. The emergence of hepatitis B as a sexually transmitted disease. Med Clin N Am. 1990;74(6):1529–41.CrossRef
42.
go back to reference Hundie GB, Raj VS, GebreMichael D, Haagmans BL. Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia. J Med Virol. 2017;89(7):1300–3.CrossRef Hundie GB, Raj VS, GebreMichael D, Haagmans BL. Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia. J Med Virol. 2017;89(7):1300–3.CrossRef
43.
go back to reference Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, et al. Prevalence and risk factors for hepatitis B virus infection in Roma and non-Roma people in Slovakia. Int J Environ Res Public Health. 2018;15(5):1047.CrossRef Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, et al. Prevalence and risk factors for hepatitis B virus infection in Roma and non-Roma people in Slovakia. Int J Environ Res Public Health. 2018;15(5):1047.CrossRef
44.
go back to reference Taleban R, Moafi M, Ataei B, Yaran M, Nokhodian Z, Kassaian N, et al. Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran. Int J Prev Med. 2018;9:46.CrossRef Taleban R, Moafi M, Ataei B, Yaran M, Nokhodian Z, Kassaian N, et al. Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran. Int J Prev Med. 2018;9:46.CrossRef
Metadata
Title
Hepatitis B virus infection and its associated factors among medical waste collectors at public health facilities in eastern Ethiopia: a facility-based cross-sectional study
Authors
Degu Abate Mengiste
Abebe Tolera Dirbsa
Behailu Hawulte Ayele
Tewodros Tesfa Hailegiyorgis
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-05918-x

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.